22q11 Deletion Syndrome (Velo-Cardio-Facial syndrome), report of the first cases in Costa Rica with cytogenetic diagnosis

Authors

  • Oscar Porras Caja Costarricense del Seguro Social, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera"
  • Catalina Obando Jiménez Caja Costarricense del Seguro Social, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera"
  • Carlos Mas Caja Costarricense del Seguro Social, Hospital Nacional de Niños "Dr. Carlos Sáenz Herrera"

DOI:

https://doi.org/10.51481/amc.v53i1.703

Keywords:

22q11 deletion syndrome, Velo-cardio-facial syndrome, Di George sequence, congenital heart disease, cleft palate, immunodeficiency, FISH

Abstract

The 22q11 deletion syndrome is an autosomic recessive disease caused by a 22q11 microdeletion. We report the first 3 cases of this syndrome in Costa Rica, confirmed by cytogenetics, in situ fluorescence hybridization showed the 22q11 microdeletion. Due to clinical suspicion it was requested in 2 boys and one girl with congenital conotruncal heart disease. As of today, 2 of the cases are alive and 1 died in the immediate postoperative period of corrective cardiac surgery. When their symptoms began, in the 3 cases failure to thrive was noted and in 2, dimorphism related to abnormal facial features. In 1 case, cleft palate was recorded and, pie bott in another. Although congenital heart disease is a clinical finding that frequently persuades physicians into thinking about this syndrome, the most common phenotypical signs are cognitive and behavioral disorders.

Downloads

Download data is not yet available.

References

Gothelf D, Frisch A, Michaelowsky E, Weizman A Shprintzen RJ. Velo-Cardio-Facial Syndrome. J Ment Health Res Intellect Disabil 2009; 2:149-167.

Di George AM, Lischner HW, Dacou C, Arey JB. Absence of the thymus. Lancet 1967; 1:1387.

Sullivan KE. Chromosome 22q11.2 deletion syndrome: Di George syndrome/velocardiofacial syndrome. Immunol Allergy Clin N Am 2008; 28: 353-366.

Sullivan KE. Di George Syndrome and Chromosome 22q11.2 deletion syndrome. En: Stiehm ER, Ochs HD, Winkelstein JA, eds.

Immunologic disorders in infants and children. 5th edition. Philadelphia: Elsevier Saunders, 2004: 523-530.

Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004; 89:148-151.

Oskarsdóttir S, Persson C, Eriksson BO, Fasth A. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur J Pediatr 2005; 164: 146-153.

Shprintzen RJ. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008; 14:3-10.

Emanuel BS. Molecular mechanisms and diagnosis of chromosome 22q11.2 rearrangements. Dev Disabil Res Rev 2008; 14: 11-18.

Manual de procedimientos del Laboratorio de Citogenética-Hospital Nacional de Niños.

Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndrome. Lancet 2007; 370:1443-1452.

The Velo-Cardio-Facial Syndrome Educational Foundation. Velocardio-facial syndrome: specialist fact sheet. En: http://www.vcfsef. org/pdf/VCFS_Factsheet_07.pdf. Consultado el 28 de octubre de 2010.

Butts SC. The facial phenotype of the velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol 2009; 73: 343-350.

Oskarsdóttir S, Holmberg E, Fasth A, Strömland. Facial features in children with the 22q11 deletion syndrome. Acta Paediatr 2008; 97:

-1117.

Downloads

Published

2011-01-03

How to Cite

22q11 Deletion Syndrome (Velo-Cardio-Facial syndrome), report of the first cases in Costa Rica with cytogenetic diagnosis. (2011). Acta Médica Costarricense , 53(1), 37-41. https://doi.org/10.51481/amc.v53i1.703